Literature DB >> 23015060

Phosphoinositide 5-phosphatases: How do they affect tumourigenesis?

Keiji Miyazawa1.   

Abstract

The activity of biological molecules is often affected by their phosphorylation state. Regulatory phosphorylation operates as a binary switch and is usually controlled by counteracting kinases and phosphatases. However, phosphatidylinositol (PtdIns) has three phosphorylation sites on its inositol ring. The phosphorylation status of PtdIns is controlled by multiple kinases and phosphatases with distinct substrate specificities, serving as a 'lipid code' or 'phosphoinositide code'. Class I phosphoinositide 3-kinase (PI3K) converts PtdIns(4,5)P₂ to PtdIns(3,4,5)P₃, which plays a pivotal role in signals controlling glucose uptake, cytoskeletal reorganization, cell proliferation and apoptosis. PI3K is pro-oncogenic, whereas phosphoinositide phosphatases that degrade PtdIns(3,4,5)P₃ are not always anti-oncogenic. Recent studies have revealed the unique characteristics of phosphoinositide 5-phosphatases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015060      PMCID: PMC3527994          DOI: 10.1093/jb/mvs107

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  22 in total

1.  Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.

Authors:  Clare G Fedele; Lisa M Ooms; Miriel Ho; Jessica Vieusseux; Sandra A O'Toole; Ewan K Millar; Elena Lopez-Knowles; Absorn Sriratana; Rajendra Gurung; Laura Baglietto; Graham G Giles; Charles G Bailey; John E J Rasko; Benjamin J Shields; John T Price; Philip W Majerus; Robert L Sutherland; Tony Tiganis; Catriona A McLean; Christina A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-02       Impact factor: 11.205

Review 2.  Inositol polyphosphate 5-phosphatases; new players in the regulation of cilia and ciliopathies.

Authors:  Sarah E Conduit; Jennifer M Dyson; Christina A Mitchell
Journal:  FEBS Lett       Date:  2012-07-22       Impact factor: 4.124

3.  INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse.

Authors:  Monique Jacoby; James J Cox; Stéphanie Gayral; Daniel J Hampshire; Mohammed Ayub; Marianne Blockmans; Eileen Pernot; Marina V Kisseleva; Philippe Compère; Serge N Schiffmann; Fanni Gergely; John H Riley; David Pérez-Morga; C Geoffrey Woods; Stéphane Schurmans
Journal:  Nat Genet       Date:  2009-08-09       Impact factor: 38.330

4.  The PtdIns(3,4)P(2) phosphatase INPP4A is a suppressor of excitotoxic neuronal death.

Authors:  Junko Sasaki; Satoshi Kofuji; Reietsu Itoh; Toshihiko Momiyama; Kiyohiko Takayama; Haruka Murakami; Shinsuke Chida; Yuko Tsuya; Shunsuke Takasuga; Satoshi Eguchi; Ken Asanuma; Yasuo Horie; Kouichi Miura; Elizabeth Michele Davies; Christina Mitchell; Masakazu Yamazaki; Hirokazu Hirai; Tadaomi Takenawa; Akira Suzuki; Takehiko Sasaki
Journal:  Nature       Date:  2010-05-12       Impact factor: 49.962

Review 5.  Translation of the phosphoinositide code by PI effectors.

Authors:  Tatiana G Kutateladze
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

6.  Regulation of IGF-1/PI3K/Akt signalling by the phosphoinositide phosphatase pharbin.

Authors:  Feng Wang; Takeshi Ijuin; Toshiki Itoh; Tadaomi Takenawa
Journal:  J Biochem       Date:  2011-03-23       Impact factor: 3.387

7.  Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death.

Authors:  Marina V Kisseleva; Li Cao; Philip W Majerus
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

8.  Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies.

Authors:  Stephanie L Bielas; Jennifer L Silhavy; Francesco Brancati; Marina V Kisseleva; Lihadh Al-Gazali; Laszlo Sztriha; Riad A Bayoumi; Maha S Zaki; Alice Abdel-Aleem; Rasim Ozgur Rosti; Hulya Kayserili; Dominika Swistun; Lesley C Scott; Enrico Bertini; Eugen Boltshauser; Elisa Fazzi; Lorena Travaglini; Seth J Field; Stephanie Gayral; Monique Jacoby; Stephane Schurmans; Bruno Dallapiccola; Philip W Majerus; Enza Maria Valente; Joseph G Gleeson
Journal:  Nat Genet       Date:  2009-08-09       Impact factor: 38.330

Review 9.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations.

Authors:  Jeffrey A Engelman
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

10.  Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1.

Authors:  Ivan Ivetac; Rajendra Gurung; Sandra Hakim; Kristy A Horan; David A Sheffield; Lauren C Binge; Philip W Majerus; Tony Tiganis; Christina A Mitchell
Journal:  EMBO Rep       Date:  2009-03-27       Impact factor: 8.807

View more
  3 in total

1.  The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: Functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines.

Authors:  Ognian C Ikonomov; Catherine Filios; Diego Sbrissa; Xuequn Chen; Assia Shisheva
Journal:  Biochem Biophys Res Commun       Date:  2013-09-23       Impact factor: 3.575

2.  INPP5E Preserves Genomic Stability through Regulation of Mitosis.

Authors:  Elizabeth A Sierra Potchanant; Donna Cerabona; Zahi Abdul Sater; Ying He; Zejin Sun; Jeff Gehlhausen; Grzegorz Nalepa
Journal:  Mol Cell Biol       Date:  2017-03-01       Impact factor: 4.272

Review 3.  PI(3,4)P2 Signaling in Cancer and Metabolism.

Authors:  Luca Gozzelino; Maria Chiara De Santis; Federico Gulluni; Emilio Hirsch; Miriam Martini
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.